A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia.
Am J Hematol
; 91(10): 1020-5, 2016 Oct.
Article
en En
| MEDLINE
| ID: mdl-27387131
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Leucemia Linfocítica Crónica de Células B
/
Anticuerpos Monoclonales
Tipo de estudio:
Diagnostic_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Hematol
Año:
2016
Tipo del documento:
Article